REDUCTION OF BUDESONIDE AFTER A YEAR OF INCREASED USE - A RANDOMIZED CONTROLLED TRIAL TO EVALUATE WHETHER IMPROVEMENTS IN AIRWAY RESPONSIVENESS AND CLINICAL ASTHMA ARE MAINTAINED

被引:124
作者
JUNIPER, EF
KLINE, PA
VANZIELEGHEM, MA
HARGREAVE, FE
机构
[1] ST JOSEPHS HOSP,FIRESTONE REG CHEST & ALLERGY UNIT,HAMILTON L8N 1Y4,ONTARIO,CANADA
[2] MCMASTER UNIV,DEPT MED,HAMILTON L8N 3Z5,ONTARIO,CANADA
[3] ASTRA PHARMA,MISSISSAUGA,ONTARIO,CANADA
关键词
D O I
10.1016/0091-6749(91)90006-A
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
We have demonstrated recently that 1 year of regular inhaled budesonide use can produce substantial improvements in airway responsiveness accompanied by significant improvements in clinical asthma severity. The present study was designed to evaluate whether these improvements are maintained when the dose of budesonide is reduced. At the end of the original study, 28 subjects with asthma, who had been in the active-treatment arm of the study were randomized either to continue taking the dose of budesonide taken in the original study or to have the dose reduced. Airway responsiveness to methacholine, bronchodilator requirements, symptoms, and spirometry were assessed after 6 weeks and 3 months. During the 3 months, no subject experienced an asthma exacerbation, and there was no evidence of change in airway responsiveness in subjects who had their steroids reduced (provocative concentration causing a 20% drop in FEV1: initial, 2.03 mg/ml; final, 1.91 mg/ml), and this change was not different from change in subjects maintained with a higher dose (initial, 3.02 mg/ml; final, 3.12 mg/ml) (p = 0.39). Similarly, there was no evidence of any change in bronchodilator requirements (p = 0.89). However, after 3 months of reduced steroid use, there was a small decline in spirometry (FEV1 percent predicted: initial, 84.4%; final, 81.5%), and this change was significantly different from change in subjects in whom steroids were not reduced (initial, 90.2%; final, 90.2%) (p = 0.002). At 3 months, symptoms (predominantly sputum production) were also beginning to redevelop in the reduced budesonide group (p = 0.056). The results suggest that, when inhaled steroids are reduced after prolonged treatment, improvements in airway responsiveness can be maintained for at least 3 months and that a deterioration in spirometry and symptoms may precede an increase in responsiveness.
引用
收藏
页码:483 / 489
页数:7
相关论文
共 14 条
[1]   EFFECT OF TOPICAL CORTICOSTEROIDS ON SEASONALLY INDUCED INCREASES IN NASAL MAST-CELLS [J].
GOMEZ, E ;
CLAGUE, JE ;
GATLAND, D ;
DAVIES, RJ .
BRITISH MEDICAL JOURNAL, 1988, 296 (6636) :1572-1573
[2]   THE ASSESSMENT AND TREATMENT OF ASTHMA - A CONFERENCE REPORT [J].
HARGREAVE, FE ;
DOLOVICH, J ;
NEWHOUSE, MT .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (06) :1098-1111
[3]   EFFECT OF PREDNISONE AND BECLOMETHASONE DIPROPRIONATE ON AIRWAY RESPONSIVENESS IN ASTHMA - A COMPARATIVE-STUDY [J].
JENKINS, CR ;
WOOLCOCK, AJ .
THORAX, 1988, 43 (05) :378-384
[4]   AIRWAY RESPONSIVENESS TO HISTAMINE AND METHACHOLINE - RELATIONSHIP TO MINIMUM TREATMENT TO CONTROL SYMPTOMS OF ASTHMA [J].
JUNIPER, EF ;
FRITH, PA ;
HARGREAVE, FE .
THORAX, 1981, 36 (08) :575-579
[5]   REPRODUCIBILITY AND COMPARISON OF RESPONSES TO INHALED HISTAMINE AND METHACHOLINE [J].
JUNIPER, EF ;
FRITH, PA ;
DUNNETT, C ;
COCKCROFT, DW ;
HARGREAVE, FE .
THORAX, 1978, 33 (06) :705-710
[6]   EFFECT OF LONG-TERM TREATMENT WITH AN INHALED CORTICOSTEROID (BUDESONIDE) ON AIRWAY HYPERRESPONSIVENESS AND CLINICAL ASTHMA IN NONSTEROID-DEPENDENT ASTHMATICS [J].
JUNIPER, EF ;
KLINE, PA ;
VANZIELEGHEM, MA ;
RAMSDALE, EH ;
OBYRNE, PM ;
HARGREAVE, FE .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (04) :832-836
[7]  
JUNIPER EF, IN PRESS EUR RESPIR
[8]   DOSAGE AND TIME EFFECTS OF INHALED BUDESONIDE ON BRONCHIAL HYPERREACTIVITY [J].
KRAAN, J ;
KOETER, GH ;
VANDERMARK, TW ;
BOORSMA, M ;
KUKLER, J ;
SLUITER, HJ ;
DEVRIES, K .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (01) :44-48
[9]   CHANGES IN BRONCHIAL HYPERREACTIVITY INDUCED BY 4 WEEKS OF TREATMENT WITH ANTIASTHMATIC DRUGS IN PATIENTS WITH ALLERGIC-ASTHMA - A COMPARISON BETWEEN BUDESONIDE AND TERBUTALINE [J].
KRAAN, J ;
KOETER, GH ;
VANDERMARK, TW ;
SLUITER, HJ ;
DEVRIES, K .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 76 (04) :628-636
[10]   DAMAGE OF THE AIRWAY EPITHELIUM AND BRONCHIAL REACTIVITY IN PATIENTS WITH ASTHMA [J].
LAITINEN, LA ;
HEINO, M ;
LAITINEN, A ;
KAVA, T ;
HAAHTELA, T .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1985, 131 (04) :599-606